The report "Interventional Cardiology & Peripheral Vascular Devices Market (Angioplasty Balloon, Stent, Catheters, EVAR Stent Grafts, Abdominal Aortic Aneurysm, IVC Filter, Plaque Modification, Hemodynamic Flow Alteration, Accessories, Guidewire) - Forecasts to 2021", This report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the interventional cardiology and peripheral vascular devices market, along with revenue estimates & forecasts and market share analysis.
http://www.marketsandmarkets.com/Market-Reports/minimally-invasive-interventional-cardiology-devices-market-548.html
The global interventional cardiology and peripheral vascular devices market is expected to reach USD 31.47 Billion by 2021 from USD 21.83 Billion in 2016, at a CAGR of 7.1% from 2016 to 2021. Rising aging population, rising incidence of cardiovascular diseases, increasing demand of minimally invasive procedures, and technological advancements are the major factors driving the growth of this market.
Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=548
On the basis of region, the global interventional cardiology and peripheral vascular devices market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the highest CAGR during the forecast period. Growth in this regional segment is driven by factors such as the rising prevalence of cardiovascular diseases, increasing number of conferences & symposia, and increasing focus of major players on the Asian market.
Some of the major players operating in the interventional cardiology and peripheral vascular devices market are Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), B. Braun Melsungen AG (Germany), Cordis Corporation (U.S.), C.R. Bard, Inc. (U.S.), Medtronic plc (U.S.), and Terumo Corporation (Japan).